153 related articles for article (PubMed ID: 34099411)
1. Association of guideline-concordant initial systemic treatment with clinical and economic outcomes among older women with metastatic breast cancer in the United States.
Vyas A; Mantaian T; Kamat S; Kurian S; Kogut S
J Geriatr Oncol; 2021 Sep; 12(7):1092-1099. PubMed ID: 34099411
[TBL] [Abstract][Full Text] [Related]
2. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
Vyas AM; Aroke H; Kogut S
J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
[TBL] [Abstract][Full Text] [Related]
3. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
[No Abstract] [Full Text] [Related]
4. Association of guideline-concordant care with survival, health care utilization, and costs among older women with advanced epithelial ovarian cancer.
Kamat S; Brown BR; Hume A; Vyas A
Am J Manag Care; 2023 Oct; 29(10):e292-e298. PubMed ID: 37870550
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis.
Vyas A; Gabriel M; Kurian S
Breast Cancer (Dove Med Press); 2021; 13():259-269. PubMed ID: 33880062
[TBL] [Abstract][Full Text] [Related]
6. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
[TBL] [Abstract][Full Text] [Related]
7. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.
Poorvu PD; Vaz-Luis I; Freedman RA; Lin NU; Barry WT; Winer EP; Hassett MJ
Breast Cancer Res Treat; 2018 Apr; 168(3):727-737. PubMed ID: 29332137
[TBL] [Abstract][Full Text] [Related]
8. Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.
Gold HT; Shao H; Oratz R; Yu O; Hammer M; Richardson S; Boudreau D
Am J Clin Oncol; 2020 Feb; 43(2):101-106. PubMed ID: 31850918
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors.
Lakkad M; Martin B; Li C; Harrington S; Dayer L; Painter JT
Clin Breast Cancer; 2023 Aug; 23(6):598-619. PubMed ID: 37328334
[TBL] [Abstract][Full Text] [Related]
10. Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.
Williams CP; Kenzik KM; Azuero A; Williams GR; Pisu M; Halilova KI; Ingram SA; Yagnik SK; Forero A; Bhatia S; Rocque GB
Oncologist; 2019 Jan; 24(1):31-37. PubMed ID: 30120157
[TBL] [Abstract][Full Text] [Related]
11. Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States.
Nadpara PA; Madhavan SS; Tworek C; Sambamoorthi U; Hendryx M; Almubarak M
J Geriatr Oncol; 2015 Mar; 6(2):101-10. PubMed ID: 25604094
[TBL] [Abstract][Full Text] [Related]
12. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
Nadpara P; Madhavan SS; Tworek C
Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
[TBL] [Abstract][Full Text] [Related]
13. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
14. Differences in Medicare Expenditures Between Appalachian and Nationally Representative Cohorts of Elderly Women With Breast Cancer: An Application of Decomposition Technique.
Vyas A; Madhavan SS; Sambamoorthi U
J Natl Compr Canc Netw; 2017 May; 15(5):578-587. PubMed ID: 28476737
[No Abstract] [Full Text] [Related]
15. Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.
Vyfhuis MAL; Suzuki I; Bentzen SM; Cullen KJ; Goloubeva OG
Oncologist; 2021 Jul; 26(7):579-587. PubMed ID: 33783061
[TBL] [Abstract][Full Text] [Related]
16. Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.
LeMasters T; Madhavan SS; Sambamoorthi U; Hazard-Jenkins HW; Kelly KM; Long D
J Natl Compr Canc Netw; 2018 Jun; 16(6):703-710. PubMed ID: 29891521
[No Abstract] [Full Text] [Related]
17. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
[TBL] [Abstract][Full Text] [Related]
18. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
[TBL] [Abstract][Full Text] [Related]
19. Guideline Discordance and Patient Cost Responsibility in Medicare Beneficiaries With Metastatic Breast Cancer.
Williams CP; Azuero A; Kenzik KM; Pisu M; Nipp RD; Bhatia S; Rocque GB
J Natl Compr Canc Netw; 2019 Oct; 17(10):1221-1228. PubMed ID: 31590153
[TBL] [Abstract][Full Text] [Related]
20. Regional Medicare Expenditures and Survival Among Older Women With Localized Breast Cancer.
Tannenbaum S; Soulos PR; Herrin J; Mougalian S; Long JB; Wang R; Ma X; Gross CP; Xu X
Med Care; 2017 Dec; 55(12):1030-1038. PubMed ID: 29068906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
